Ishita Drugs Statements
52
Data from Ishita Drugs`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
INR - Indian rupee
Last reporting period:
30 Sep, 2023
Next reporting period:
28 Mar, 2024
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
06 Nov, 2024
Ishita Drugs Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
74.813
27.2 %
100
54.112
75
20.701
15 %
25
—
0
6.569
7.9
17.497
19.7 %
20.8
3.204
-5.2 %
4.2
-0.33
-0.2
1.7
2.2
4.574
14 %
6.3
1.1
1.5
3.474
18.2 %
4.8
1.163
2.987
58.832
-4.9 %
100
40.837
66.7
17.996
4.6 %
33.3
—
0
6.875
13.3
14.615
2.5 %
25.4
3.381
14.8 %
7.9
-0.484
-1.7
1.113
3.3
4.01
6 %
9.6
1.07
2.7
2.94
3.7 %
6.8
0.983
2.99
61.891
—
100
44.688
72.9
17.203
—
27.1
—
0
5.96
10.6
14.259
—
23.4
2.944
—
3.7
-0.052
-0.06
0.892
1.9
3.784
—
5.5
0.95
1.4
2.834
—
4.1
0.948
2.99